| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Rheumatology | 37 / 77 | 52nd | Q2 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Advances in Rheumatology
Advances in Rheumatology is Scopus-indexed (Q2, CiteScore 3.6), WoS SCIE, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 2523-3106Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Advances in Rheumatology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2018–present, best quartile Q2, CiteScore 3.6.
What quartile is Advances in Rheumatology in Scopus?
Advances in Rheumatology is Q2 in Rheumatology (rank 37 of 77), by CiteScore 2025.
What is the impact factor of Advances in Rheumatology?
Advances in Rheumatology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.6, which places it in quartile Q2 at the 52nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.722, quartile Q2, with an H-index of 45.
How much does it cost to publish in Advances in Rheumatology?
The publisher lists an article processing charge of about US$2,490 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Advances in Rheumatology and what is its ISSN?
Advances in Rheumatology is published by BioMed Central Ltd. Its ISSN is 2523-3106.
Is Advances in Rheumatology in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Advances in Rheumatology open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Advances in Rheumatology? — open metrics via OpenAlex
Advances in Rheumatology has an h-index of 55 and a 2-year mean of 2.92 citations per paper (OpenAlex). Its Scopus CiteScore is 3.6, quartile Q2. On 2-year citations it ranks #19 of 74 Scopus journals in Rheumatology.
Advances in Rheumatology published 76 papers in 2025; its busiest recent year was 2017 with 697. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Are there integrity warnings for Advances in Rheumatology? — indicators, not proof of misconduct
Scopus status: Active. 1 retracted paper is recorded (0.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 1 · 0.3 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.